Stock search

Ticker or company name

Compare stocks

Market: US

  • SOLVSolventum
  • BAXBaxter International
  • ZBHZimmer Biomet

Add stock

Ticker or company

Summary

SOLV
Solventum
$88,65Down −0,48%
Year: Up +18%

Not enough data for a score

Open stock page
BAX
Baxter International
$25,54Down −1,05%
Year: Up +38%
38/100Ratio would not consider buying
Open stock page
ZBH
Zimmer Biomet
$101,41Down −1,74%
Year: Up +14%
67/100Best scoreRatio would watch
Open stock page

Verdict

ZBH has the best score (67). ZBH grows revenue the fastest. ZBH is the cheapest by forward P/E. BAX has the lowest debt load. ZBH has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckSOLV1 ✓ 0 — 1 ✕BAX2 ✓ 2 — 4 ✕ZBH4 ✓ 4 — 1 ✕
P/E vs its historyn/a96,3—26,0
P/E vs industry96,3—26,0
Forward P/E12,3n/a11,210,5
Revenue growth, YoYn/a—+5,3%+7,0%
EPS growth, YoYn/a——−1,7%
Net marginn/a—−6,2%9,0%
Net debt / EBITDAn/a—−2,72,6
Free cash flown/a—$1,64 bn$1,64 bn
Share count over a yearn/a—+1,2%−3,7%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterSOLVTTMBAXTTMZBHTTMIndustry medianTTM
P/E TTM ↓Worst: 96,3n/aBest: 26,025,1
Forward P/E ↓Worst: 12,311,2Best: 10,516,2
PEG ↓n/a−0,14,32,2
P/S TTM ↓1,9Best: 1,2Worst: 2,32,2
EV/EBITDA ↓20,5Worst: 81,5Best: 14,817,3
P/FCF ↓Worst: 55,2Best: 11,717,219,5

Price, %

  • SOLVn/a
  • BAXn/a
  • ZBHn/a

Returns

Best WorstNo mark — in between

PeriodSOLVBAXZBH
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

SOLVBAXZBH
Share of “buy”Best: 59%Worst: 25%32%
Beat the forecastBest: 4 of 4Worst: 3 of 4Worst: 3 of 4
Average “surprise”+11,6%Best: +14,9%Worst: +3,2%
Insiders over 12 monthspurchases $100 344no tradessales $1,58 m

Details are on each stock page.